Determination of free serotonin and its metabolite 5-HIAA in blood human samples with consideration to pre-analytical factors

Biomedical Chromatography

Volumn 28, Issue 12, 2014, Pages 1641-1646

  Yubero Lahoz, Samanta ^a,b   Rodríguez, Joan ^b   Faura, Anna ^b   Pascual, Julio ^b   Oliveras, Anna ^b   Cao, Higini ^b   Farré, Magí ^b,c   de la Torre, Rafael ^a,b,d  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

Blood; Microdialysis; Platelet; Platelet poor plasma; Serotonin

Indexed keywords

CHEMICAL DETECTION; DIALYSIS; DISEASE CONTROL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLITES; PLASMA (HUMAN);

BLOOD; ELECTROCHEMICAL DETECTION; EX-VIVO; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; MICRO-DIALYSIS; PHYSIOLOGICAL LEVELS; PLATELET-POOR-PLASMAS; SAMPLE MANIPULATION; SENSITIVITY LIMIT; SEROTONIN;

PLATELETS;

5 HYDROXYINDOLEACETIC ACID; CITRATE SODIUM; EDETIC ACID; HEPARIN; LITHIUM HEPARIN; SEROTONIN; UNCLASSIFIED DRUG;

5 HYDROXYINDOLEACETIC ACID BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CENTRIFUGATION; CLINICAL ARTICLE; COLD; ELECTROCHEMICAL DETECTION; END STAGE RENAL DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; METHODOLOGY; MICRODIALYSIS; RELIABILITY; SEROTONIN BLOOD LEVEL; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE POOR PLASMA; BLOOD; BLOOD SAMPLING; CHEMISTRY; CHRONIC KIDNEY FAILURE; REPRODUCIBILITY;

BLOOD PLATELETS; BLOOD SPECIMEN COLLECTION; CENTRIFUGATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEPARIN; HUMANS; HYDROXYINDOLEACETIC ACID; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MICRODIALYSIS; REPRODUCIBILITY OF RESULTS; SEROTONIN;

EID: 84911952022     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.3192     Document Type: Article

References (27)

1. Beck O, Wallen NH, Broijersen A, Larsson PT and Hjemdahl P. On the accurate determination of serotonin in human plasma. Biochemical and Biophysical Research Communication 1993; 196: 260-266.
2. Berger M, Gray JA and Roth BL. The expanded biology of serotonin. Annual Review of Medicine 2009; 60: 355-366.
3. Brand T and Anderson GM. The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clinical Chemistry 2011; 57: 1376-1386.
4. Brenner B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL and Kilic F. Plasma serotonin levels and the platelet serotonin transporter. Journal of Neurochemistry 2007; 102: 206-215.
5. Cheng FC, Yang LL, Chang FM, Chia LG and Kuo JS. Simultaneous measurement of serotonin, catecholamines and their metabolites in cat and human plasma by in vitro microdialysis-microbore high-performance liquid chromatography with amperometric detection. Journal of Chromatography 1992; 582: 19-27.
6. Cheng FC, Kuo JS, Chang WH, Juang DJ, Shih Y and Lai JS. Rapid and reliable high-performance liquid chromatographic method for analysing human plasma serotonin, 5-hydroxyindoleacetic acid, homovanillic acid and 3, 4-dihydroxyphenylacetic acid. Journal of Chromatography 1993; 617: 227-232.
7. Dupuis L, Spreux-Varoquaux O, Bensimon G, Jullien P, Lacomblez L, Salachas F, Bruneteau G, Pradat PF, Loeffler JP and Meininger V. Platelet serotonin level predicts survival in amyotrophic lateral sclerosis. PloS One 2010; 5: e13346. doi: 10.1371/journal.pone.0013346.
8. Herve P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P and Drouet L. Increased plasma serotonin in primary pulmonary hypertension. American Journal of Medicine 1995; 99: 249-254.
9. Javors MA, Seneviratne C, Roache JD, Ait-Daoud N, Bergeson SE, Walss-Bass MC, Akhtar FZ and Johnson BA. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Progress in Neuropsychopharmacology and Biological Psychiatry 2005; 29: 7-13.
10. Kerr PG, Argiles A and Mion C. Whole blood serotonin levels are markedly elevated in patients on dialytic therapy. American Journal of Nephrology 1992; 12: 14-18.
11. Lederer DJ, Horn EM, Rosenzweig EB, Karmally W, Jahnes M, Barset RJ and Kawut SM. Plasma serotonin levels are normal in pulmonary arterial hypertension. Pulmonary Pharmacology and Therapeutics 2008; 21: 112-114.
12. Matuchansky C and Launay JM. Serotonin, catecholamines, and spontaneous midgut carcinoid flush: plasma studies from flushing and nonflushing sites. Gastroenterology 1995; 108: 743-751.
13. Mercado CP and Kilic F. Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels. Molecular Interventions 2010; 10: 231-241.
14. Middelkoop CM, Dekker GA, Kraayenbrink AA and Popp-Snijders C. Platelet-poor plasma serotonin in normal and preeclamptic pregnancy. Clinical Chemistry 1993; 39: 1675-1678.
15. Montgomery RK, Reddoch KM, Evani SJ, Cap AP and Ramasubramanian AK. Enhanced shear-induced platelet aggregation due to low-temperature storage. Transfusion 2013; 53: 1520-1530.
16. Ohkawa R, Hirowatari Y, Nakamura K, Ohkubo S, Ikeda H, Okada M, Tozuka M, Nakahara K and Yatomi Y. Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples. Clinical Biochemistry 2005; 38: 1023-1026.
17. Paez X and Hernandez L. Simultaneous brain and blood microdialysis study with a new removable venous probe. Serotonin and 5-hydroxyindolacetic acid changes after d-norfenfluramine or fluoxetine. Life Sciences 1996; 58: 1209-1921.
18. Paez X and Hernandez L. Plasma serotonin monitoring by blood microdialysis coupled to high-performance liquid chromatography with electrochemical detection in humans. Journal of Chromatography B: Biomedical Sciences and Applications 1998; 720: 33-38.
19. Patel BA, Arundell M, Parker KH, Yeoman MS and O'Hare D. Simple and rapid determination of serotonin and catecholamines in biological tissue using high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2005; 818: 269-276.
20. Sebekova K, Spustova V, Opatrny K and Dzurik R. Serotonin and 5-hydroxyindole-acetic acid. Bratislavslé Lekárske Listy 2001; 102: 351-356.
21. US Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research: Rockville, MD, 2001. Available from: http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf [Accessed 2013 February 7].
22. van der Meer PF and de Korte D. Platelet preservation: agitation and containers. Transfusion and apheresis Science 2011; 44: 297-304.
23. White JG and Escolar G. EDTA-induced changes in platelet structure and function: adhesion and spreading. Platelets 2000; 11: 56-61.
24. Yan D, Urano T, Pietraszek MH, Shimoyama I, Uemura K, Kojima Y, Sakakibara K, Serizawa K, Takada Y and Takada A. Correlation between serotonergic measures in cerebrospinal fluid and blood of subhuman primate. Life Siences 1993; 52: 745-749.
25. Yubero-Lahoz S, Ayestas MA, Blough BE, Partilla JS, Rothman RB, de la Torre R and Baumann MH. Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain. European Journal of Pharmacology 2012; 674: 337-344.
26. Yubero-Lahoz S, Robledo P, Farré M and de la Torre R. Platelet SERT as a peripheral biomarker of serotonergic neurotransmission in the central nervous system. Current Medicinal Chemistry 2013; 20: 1382-1396.
27. Zolkowska D, Rothman RB and Baumann MH. Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease. The Journal of Pharmacology and Experimental Therapeutics 2006; 318: 604-610.